The environment ministry in India will make the final call after the Genetic Engineering Appraisal Committee recently gave a positive recommendation for the commercial cultivation of GM mustard. Whether the crop is commercially cultivated could depend on the Supreme Court, which is hearing a case seeking a moratorium on its commercial release. The government has stated it will abide by the courts decision (although that remains to be seen and some question the courts impartiality). The final hearing will probably take place in July. The casebefore the Supreme Court was brought by Aruna Rodrigues who accuses various officials and the regulatory authorities of unremitting fraud and regulatory delinquency.
The importance of GM mustard should not be underestimated. It is central to the whole debate about the future of agriculture in India and the wider development paradigm. GM mustard is a Trojan horse that would help pave the way for ripping up the economic and social fabric of India and recast for the benefit of powerful Western corporations, not least Bayer-Monsanto (seeGM Mustard in Indiato read my numerous articles on this issue).
GM mustard is being promoted on the basis of the lie that it will increase yield. However, the government itself admits theres no evidence that it will do so.In aletterto Anil Dave, Indias environment minister, presented below, advocate Prashant Bhushan says that conclusions were drawn and disseminated to mean that GM Mustard DMH 11 is a superior hybrid-making technology that will out-yield Indias best non-GMO hybrids and varieties. But he adds that non-GMO hybrids and varieties out-yield HT DMH 11 hands down.
Bhushan reminds the Indian government that it has admitted that there is no evidence that GM mustard out-yields non-GM. In an affidavit to the Supreme Court, the government stated,
No such claim has been made in any of the submitted documents that DMH 11 out-performs Non-GMO hybrids.
ANNEX
Resi. Office. Chamber
B-16,Sector-14,Noida C-67, Sector-14, Noida 301, New Lawyers Chamber
Dist. Gautam BudhNagar Dist. Gautam BudhNagar SupremeCourt Of India
(U.P.) 201 301 (U.P.) 201 301, fax: 0120-4512694 New Delhi
Ph : 0120-2512632, 2512693 Ph: 0120-2512523, 2512695 Ph: 011- 23070301,23070645.
Dated: May 13, 2017
Shri Anil DaveThe Honble Minister of MoEF and Climate Change Paryavaran Bhavan Lodhi Road New Delhi
COMMERCIAL APPROVAL BY THE GEAC OF HT MUSTARD HYBRID DMH 11ON 11 MAY 2017
Dear Shri Dave
I express a deep disquiet and anxiety at the opaque and unscientific regulatory oversight of this GM mustard, which is also an herbicide tolerant (GM) crop. It has resulted yesterday, in its undoubtedly flawed approval for Commercialisation by the GEAC. I write to request you to please withhold your approval of such a move on three grounds.
The firstis that the CJ, based on the assurance given by the AG Mukul Rohatgi that the Union of India will not release DMH 11without the prior approval of the Supreme Court,accordingly, gave a verbal Order of an interim injunction till the case is heard comprehensively and the issue of HT mustard in substance. This was widely reported in the newspapers, two examples of which are referenced ().
The secondis the grave matter of the independence, surety and rigourof the oversight of the biosafety of HT Mustard DMH 11, which is critical for Indias agriculture in mustard, its food safety (both as a vegetable and seed oil), and furthermore, and of outstanding importance, the certain contamination that will occur of Indias mustard germplasm. These matters are of course, of central concern to your Ministrys regulating function and mandate for India.
The thirdis the requirement and my personal plea to you, to take note of the lessons of history of GMO regulation in India, embedded as it is in the most serious conflicts of interest and lack of expertise, where regulation has become farcical. For this reason,self-assessed safety dossiersby crop developers are kept secret by our Regulators and governing Ministries. Four official reports attest to the prevailing, utterly dismal state of regulation.
May any government treat its citizens with such willful disregard, despite Constitutional provisions?
The Bt brinjal Biosafety-Dossier remained unpublished for 16 months despite a SC order, but eventually, the Regulators had to comply with its full publication (with the raw data), which then revealed its fraudulence when examined and appraised by independent scientists of international stature. Studies said to be done were not done, as many as 36 of 37 environmental studies, leaving aside other risk assessment protocols. The moratorium which followed was also in large part influenced by the fact thatIndia is the worlds Centre of brinjal diversitywith 2500 varieties and wild species, which would certainly be contaminated. This is what the 37thPSC of 2012 (on GMOs) had to say on Bt brinjal and regulation. I quote very briefly. I would urge you to read the full recommendations of just 3 pages:
-Convinced that these developments are not merely slippages due to oversight or human error but indicative of collusion of a worst kind,they have recommended a THOROUGH PROBE INTO THE BT. BRINJALmatter from the beginning up to the imposing of moratorium on its commercialization by the then Minister of Environment and Forests (I/C) on 9 February, 2010 by a team of independent scientists and environmentalists.(Recommendation Para No. 2.79).
The Committee after critically analyzingthe evidence the gross inadequacy of the regulatory mechanism, the absence of chronic toxicology studies and long term environment impact assessment of transgenic agricultural crops; the virtual non-existent nature of the oversight bodies like National Biodiversity Authority, Protection of Plant Varieties and Farmers Right Authority, Food Safety and Standards Authority of India, etc., recommended that till all the concerns voiced in their Report are fully addressed -, to put in place all regulatory, monitoring, oversight, surveillance and other structures,further research and development on transgenics in agricultural crops should only be done in strict containment and FIELD TRIALS UNDER ANY GARB SHOULD BE DISCONTINUED FORTHWITH.(Recommendation Para Nos. 8.116, 8.121 & 8.125)
Noting with concern the grossly inadequate and antiquated regulatory mechanism for assessment and approval of transgenics in food crops; the serious conflict of interest of various stakeholders involved in the regulatory mechanism; the total lack of post commercialization, monitoring and surveillance, the Committee have felt thatin such a situation what the Country needs is not a bio-technology regulatory legislationbut anall-encompassing umbrella legislation on bio-safety-The Committee have also cautioned the Government that in their tearing hurry to open the economy to private prospectors, they should NOT MAKE THE SAME FATE BEFALL ON THE AGRICULTURE SECTOR, as has happened to the communications, pharma, mineral wealth and several other sectors in which the Governmentsfacilitative benevolence preceded setting up of sufficient checks and balances and regulatory mechanisms,thereby, leading to colossal, unfettered loot and plunder of national wealth in some form or the other, incalculable damage to environment, bio-diversity, flora and fauna and unimaginable suffering to the common man.(Recommendation Para No. 3.47 & 3.48)
But till date, the GM mustard dossier remains unpublished in willful Contempt of Court. Prof Pental is the Chair of the DBTs Agricultural Biotechnology Task Force. SR Rao, Member GEAC is over-all in-charge of the DBTs Agri Biotech programmes.The DBT also funds Pentals GM mustard.
Does anything more need to be said to underscore the implications of thiscosyarrangement of partnership in the Regulatory oversight of HT mustard DMH 11 and GMOs in general?
Data that has leaked around the edges demonstrate that we have ample reason to be greatly concerned of gross cover-up and misconduct. Furthermore, this HT mustard DMH 11 and its two HT variants are doubly barred by the unanimous 5-member TEC recommendations: ie this is an HT crop and a crop in a Centre of genetic diversity.
The further contents of this letter below, make clear in the simplest possible way, from, and it has to be said, curious admissions of your Apex Regulator and the Union of India in their Reply Affidavit submitted to the SC, which effectively demolish wholesale, any sound basis for the release of HT DMH 11 for commercial cultivation. I make 3 short points, to alert you to the veracity of this statement, as you will not be briefed correctly on these matters by your Regulators and indeed by the Ministries of S & T and Agriculture, both of which promote HT DMH 11 and even fund it (DBT) as stated above:
(a) HT hybrid mustard DMH 11 has failed the first criteria of a test risk protocol of a GM crop:Is the GM Crop required in the first place?The answer inNobased on the admission of the Union of India itself in their Reply Affidavit in the SC.They said:
No such claim has been made in any of the submitted documents that DMH 11 out-performs Non-GMO hybrids. The comparison has only been made between hybrid DMH 11, NC (national Check) Varuna and the appropriate ZC (zonal checks) MSY of 2670 Kg/ha has been recorded over three years of BRL trials which is 28% and 37% more than the NC & ZC respectively (At 88, pg.56).
Unfortunately, the whole truth uncovered, is that no valid comparators were used and the field trials themselves stand voided on the basis of serious anomalies and violations in field testing, inconclusive results and even statistical fraud.Yet, conclusions were drawn and disseminated to mean that DMH 11 is a superiorhybrid-making technologythat will out-yield Indias best Non-GMO hybrids and varieties. The fact is, Non-GMO hybrids and varieties out-yield HT DMH 11 hands down.
(b) We know, based on the AGs assertion in Court that the Union of India holds that this GM mustard will displace imported edible oil-seeds in a significant way (reduce our oilseeds bill). However, such an assertion in the light of the above submission is to say the least ludicrous, entirely lacking any semblance of logic. Moreover, the nearest equivalent to Indian mustard (Brassica juncea) is rape-seed oil (Canola), imported from Canada (which is essentially GMO) and represents just 2% of Indias edible oil imports! Rs 68,000 Cr is the total import oil-seeds bill,not Canolaalone, as the AG mistakenly stated in Court. Can this be the basis for the Commercialisation of HT mustard DMH 11?
It gets murkier still when the U of I also admits that:
Heterosis is due to the careful selection of parents and not due to the three transgenes The developers have nowhere claimed that the yield increase is due to the three transgenes(At 65, page 45)
This is exactly the issue that there is no trait for yield in HT DMH 11. It is good indeed that on this point we are all in agreement. Yet, somehow, the opposite story prevails, the story to the media, and the PMO. The stand of the Niti Aayog is particularly curious in that their National Agri policy requires GMOs in agriculture to meet Indias food security as they are better yielding! Where in this statement is the basic science governing the trait for yield in GMOs and Mustard in particular? It is very troubling that the Niti Aayog has failed to do some basichomework.
(c) Therefore, we draw the conclusion that the stated regulatory intent is toderegulate HT DMH 11 as a policy agenda based on no science,and to convert Indias mustard agriculture, in a massive and dangerous experiment, to (GM) HThybridmustard, (variants of DMH 11). Imagine our consternation when your Regulator admitted to precisely this:
Once the GE mustard events Varuna bn 3.6 and EH2 modbs 2.99 are approved and deregulated, these would be immediately used by the National net-work programme Once a robust pollination control mechanism is in place,yield of hybrids can be further improved by breeding betterparental lines(at 63, pg. 43).
The statement is pure spin, dissimulation. Unless deconstructed, it conveys that HT Hybrid DMH11 is a superior hybrid-making technology (which it is not); that will (alone) provide 25 to 30% higher yield and even better, (not true, as admitted), because on the contrary, Indias best Non-GMO hybrids and varieties are already significantly outperforming HT DMH 11. Unfortunately and regrettably, the plain truth is that decades of good work already being done by our agri institutions and the DRMRin Non-GM hybrid technology and superior-yielding varieties will be laid waste in this dangerous plan for the country via HT Hybrid DMH 11 and its variants.
AND OUR GERMPLASM WILL BE THOROUGHLY CONTAMINATED AND IN A CENTRE OF MUSTARD DIVERSITY.
India is a centre of diversity in mustard with9720 Accessionsin our gene banks(The NBPGR). With a commercialised GM crop, contamination of non-GMO is certain. That is the evidence.
In closing, Id like to emphasise that GMO contamination is neither remediable nor reversible and is the outstanding concern. The genes in HT hybrid DMH 11 are toxic genes: being an HT crop also means that DMH 11 is a pesticidal crop. Its nationality doesnt change the science. It stays this way whether foreign or Indian! How do we get carried away on such a band-wagon?
The issue also is that with GMO contamination, our mustard will be changed at the molecular level. Any toxicity that there is will remain in perpetuity. Are we prepared to be the agents for such monumental risk and put India and its people in jeopardy without any recourse and remedy?
For these reasons among others, and there are decidedly others, I would urge you on behalf of our Nation not to endorse this outrageous and anti-national approval, but reject it in the public interest. You will be doing India a noble service in posterity.
Thank you, Yours sincerely,
Signed/
Prashant Bhushan
* * *
Notes
LiveLaw News Network: No GM Mustard Without SC Approval October 24, 2016;
Directorate of Rape-Seed Mustard
Continued here:
India: Genetic Engineering, the Commercialization of GM Mustard and the Future of Agriculture - Center for Research on Globalization
- genetic engineering summary | Britannica - September 13th, 2024
- The great gene editing debate: can it be safe and ethical? - BBC.com - September 13th, 2024
- Anti-biotechnology campaigners embrace classic crops, are suspicious of hybrid varieties and claim genetic modification violates nature. Heres a... - September 13th, 2024
- Will IL-11 Control Extend Human Life One Day? Early Results are Tantalizing - Securities.io - September 13th, 2024
- Viewpoint: As New Zealand edges toward relaxing its ban on gene edited foods, experts weigh in - Genetic Literacy Project - September 13th, 2024
- Farmers in Brazil and Argentina ramp up growing of genetically-modified drought tolerant wheat that can grow in subtropical regions - Genetic Literacy... - September 13th, 2024
- Scientist explains why we'll never have a real Jurassic Park - and people are crestfallen - indy100 - September 13th, 2024
- Genetic engineering techniques - Wikipedia - January 9th, 2024
- 20.3: Genetic Engineering - Biology LibreTexts - January 9th, 2024
- Genetic engineering - DNA Modification, Cloning, Gene Splicing - December 13th, 2023
- Global Gene Editing Market Poised for Significant Growth, Projected to Reach $14.28 Billion by 2027 - EIN News - December 13th, 2023
- Principles of Genetic Engineering - PMC - National Center for ... - May 17th, 2023
- Quitting: A Life Strategy: The Myth of Perseveranceand How the New Science of Giving Up Can Set You Free - Next Big Idea Club Magazine - May 17th, 2023
- 18 Human Genetic Engineering - Clemson University - March 29th, 2023
- Pros and Cons of Genetic Engineering - Benefits and Risks - March 29th, 2023
- How artificial skin is made and its uses, from treating burns to skin cancer - South China Morning Post - March 29th, 2023
- Genetic Engineering - Meaning, Applications, Advantages and Challenges ... - March 13th, 2023
- Revolutionary Specialty Enzymes Transform Industries, Projected to Reach $2.2 Billion by 2031 - Billion-Dollar - EIN News - March 5th, 2023
- Explained: What is genome editing technology and how is it different from GM technology? - The Indian Express - April 2nd, 2022
- Scribe Therapeutics to Participate in Upcoming Goldman Sachs The New Guard: Privates Leading the Disruption in Healthcare Investor Conference - Yahoo... - April 2nd, 2022
- San Antonio Zoo In Discussions on Woolly Mammoth Project - iHeart - April 2nd, 2022
- Xenotransplantation trials will require adjusting expectations, experts say - STAT - April 2nd, 2022
- 5 Interesting Startup Deals You May Have Missed In March: Restoring The Woolly Mammoth, Faux Seafood And Lots Of Bees - Crunchbase News - April 2nd, 2022
- Synlogic to Present Data on Phenylketonuria and Homocystinuria Programs at the Society for ... - KULR-TV - April 2nd, 2022
- The Bay Area food tech industry is creating more than vegan burgers. Heres whats next - San Francisco Chronicle - April 2nd, 2022
- Student Startup Teams to Compete For $110000 Cash Prize Pool in U of A's Heartland Challenge - University of Arkansas Newswire - April 2nd, 2022
- Should we test for differences in allergen content between varieties of crops and animal species? - Open Access Government - April 2nd, 2022
- Genetic Engineering - Courses, Subjects, Eligibility ... - December 22nd, 2021
- Scientists Used CRISPR Gene Editing to Choose the Sex of Mouse Pups - Singularity Hub - December 22nd, 2021
- Report calls for broad public deliberation on releasing gene-edited species in the wild - EurekAlert - December 22nd, 2021
- RNA and DNA Extraction Kit Market Study | Know the Post-Pandemic Scenario of the Industry - BioSpace - December 22nd, 2021
- Opinion: Allow Golden Rice to save lives - pnas.org - December 22nd, 2021
- It's time for an alliance of democracies | TheHill - The Hill - December 22nd, 2021
- Aridis Pharmaceuticals Announces a Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against the Omicron variant, other COVID-19... - December 22nd, 2021
- 2021: when the link between the climate and biodiversity crises became clear - The Guardian - December 22nd, 2021
- Wuhan lab leak now the most likely cause of Covid pandemic and the truth WILL come out, experts tell MPs... - The US Sun - December 22nd, 2021
- Biotech ETFs That Outperformed Last Week - Yahoo Finance - December 22nd, 2021
- Human genetic enhancement - Wikipedia - October 5th, 2021
- Viewpoint: Part 1 Opposition stirred by anti-GMO advocacy group propaganda fading in the developing world, as more countries embrace crop... - October 5th, 2021
- Amyris Partners with Inscripta to Enhance Development of Sustainable Ingredients Using the Onyx Genome Engineering Platform - WWNY - October 5th, 2021
- Kingdom Supercultures raises $25m to expand Non GMO suite of microbes to unlock new flavors, textures, and functionalities in food & beverage -... - October 5th, 2021
- Fact check: Genetically engineering your salad with the COVID-19 vaccines? We're not there yet. - USA TODAY - October 5th, 2021
- Making the Transition from an Academic to a Biobusiness Entrepreneur - Genetic Engineering & Biotechnology News - October 5th, 2021
- Is The New York Times Finally 'Learning To Love GMOS'? - American Council on Science and Health - October 5th, 2021
- Gene editing, joke theft and manifesting - The Week UK - October 5th, 2021
- Opinion: Saving lives through real social justice - Agri-Pulse - October 5th, 2021
- Science, business and the humanities: CP Snow's 'Two Cultures' sixty years on - TheArticle - October 5th, 2021
- Probiotic Yeast Engineered To Produce Beta-Carotene - Technology Networks - April 17th, 2021
- In the US, Imminent Release of Genetically Modified Mosquitoes To Fight Dengue - The Wire Science - April 17th, 2021
- CRISPRoff: A New Addition to the CRISPR Toolbox - Technology Networks - April 17th, 2021
- A Massive New Gene Editing Project Is Out to Crush Alzheimer's - Singularity Hub - April 17th, 2021
- Grammar of the Genome: Reading the Influence of DNA on Disease - Baylor University - April 17th, 2021
- We cannot let China set the standards for 21st century technologies | TheHill - The Hill - April 17th, 2021
- First GMO Mosquitoes to Be Released in the Florida Keys - Singularity Hub - April 17th, 2021
- Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations - BioSpace - April 17th, 2021
- AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses - OncoZine - April 17th, 2021
- StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies - BioSpace - April 17th, 2021
- ThermoGenesis : The History of Cell and Gene Therapy - marketscreener.com - April 17th, 2021
- EU's refusal to permit GMO crops led to millions of tonnes of additional CO2, scientists reveal - Alliance for Science - Alliance for Science - February 14th, 2021
- New species of fly named after Singanallur Tank - The Hindu - February 14th, 2021
- Son of Monarchs Pays Homage to the Beauty of Migration - Sierra Magazine - February 14th, 2021
- Podcast: TIME's 2020 Kid of the Year, Gitanjali Rao - All Together - Society of Women Engineers - February 14th, 2021
- Geoengineering: What could possibly go wrong? Elizabeth Kolbert's take, in her new book - Bulletin of the Atomic Scientists - February 14th, 2021
- An Introduction to PCR - Technology Networks - February 14th, 2021
- Science Talk - Evolution, cancer and coronavirus how biology's 'Theory of Everything' is key to fighting cancer and global pandemics - The Institute... - February 14th, 2021
- 22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with... - February 14th, 2021
- Aleph Farms and The Technion Reveal World's First Cultivated Ribeye Steak - PRNewswire - February 9th, 2021
- Researchers create rice that captures more CO2 with 30 percent more yield - FoodIngredientsFirst - February 9th, 2021
- Interview: Elizabeth Kolbert on why well never stop messing with nature - Grist - February 9th, 2021
- Is Biotechnology the Answer to a More Sustainable Beauty Industry? - Fashionista - February 9th, 2021
- New Jersey arts and entertainment news, features, and event previews. - New Jersey Stage - February 9th, 2021
- CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft... - February 9th, 2021
- Taysha Gene Therapies Announces Collaborations to Advance Next-Generation Mini-Gene Payloads for AAV Gene Therapies for the Treatment of Genetic... - February 9th, 2021
- A new tool to investigate bacteria behind hospital infections - MIT News - February 9th, 2021
- Outlook on the CRISPR Gene Editing Global Market to 2030 - Analysis and Forecasts - GlobeNewswire - February 9th, 2021
- Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization - GlobeNewswire - February 9th, 2021
- Global Lab-On-A-Chip Market Industry Perspective, Comprehensive Analysis, and Forecast 2027||Players-Perkin Elmer Corporation, IDEX, Thermo Fisher... - February 9th, 2021
- Freeline Presents Data on its Gaucher Disease and Fabry Disease AAV-Based Gene Therapies at the 17th Annual WORLDSymposium - PharmiWeb.com - February 9th, 2021
- Global Bacterial and Plasmid Vectors Market Report 2020: Market is Expected to Recover and Reach $0520 Million in 2023 at a CAGR of 15.48% - Forecast... - January 12th, 2021
- mRNA Technology Gave Us the First COVID-19 Vaccines. It Could Also Upend the Drug Industry - TIME - January 12th, 2021